SUPN (Supernus Corp) Bozor qiymatining balans qiymatiga nisbati
Supernus Pharmaceuticals (SUPN) psixiatrik terapiyalarning uzoq muddatli rivojlanishiga bo'lgan etik yondashuvi orqali neyrobiologlarni jalb qilmoqda. GURU.Markets platformasidagi aktivning bozor dinamikasi, u yerda ko'rsatkich 2.33 darajasida turibdi, SPN-830 nasosining salohiyati va Qelbree muvaffaqiyatiga bog'liq. Kompaniyaning moliyaviy barqarorligi unga birlashish va sotib olish bitimlarini amalga oshirish imkonini beradi. Kelajakdagi istiqbollar dori vositalarini yetkazib berish tizimlarini takomillashtirish va terapevtik sohalarni kengaytirishga asoslanadi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_SUPN_-_Supernus-Pharmaceuticals_-_Capitalization-to-Book-Value-Ratio "SUPN Supernus Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 29.10.2026) | 👁️GURU.Markets👁️")
Supernus Pharmaceuticals, Inc. (SUPN) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Supernus Pharmaceuticals|SUPN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Supernus Pharma|SUPN - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Supernus Pharma|SUPN - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli majburiyatlari Supernus
Fundamental baholash:Supernus Pharmaceuticals (SUPN)
ADHD va epilepsiya davolash vositalarining patent bilan himoyalangan tor sohasi Supernus Pharmaceuticals (SUPN) kompaniyasiga barqaror marjlar va bashorat qilinadigan pul oqimini ta'minlaydi. Bozor kapitalizatsiyasining kitob qiymatiga nisbati ko'rsatkichidagi o'zgarishlarni tahlil qilish orqali investorlar sof aktivlardan yuqori bo'lgan bozor qiymati premiumini baholaydilar, bu esa ularga kompaniyaning intellektual kapitali uchun haddan tashqari to'lov miqdorini aniqlash va fundamental aktivlarning qiymati pasayishi risklarini o'z vaqtida tan olish imkonini beradi.
Asosiy raqobatchilar
Bozor qiymatining balans qiymatiga nisbati Biogen Inc.|NBIX (neurocrine.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|catalystpharma.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Denali Therapeutics Inc. (DNLI)|HRMY: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati BHVN|AMLX (Amylyx Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|TRVI: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi praxismedicines.com (PRAX)|Kapitallashuvning sof aktivlarga nisbati AVXL|Bozor kapitallashuvining balans qiymatiga nisbati CBLL (CeriBell Inc)|prothena.com (PRTA) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Alector Inc. ALEC|ANNX (Annexon, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|OMER: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Neurogene NGNE|ACIU (AC Immune S.A.) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Voyager Pharma (VYGR)|Kapitallashuvning balans qiymatiga nisbati Neumora Corp (NMRA)|Kapitallashuvning sof aktivlarga nisbati SCLX|Bozor kapitallashuvining balans qiymatiga nisbati TVGN (tevogen.com)|Bozor qiymatining balans qiymatiga nisbati ACOG|CGTX - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Inhibikase (IKT)|SAVA: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati assertiotx.com (ASRT)|Coya Therapeutics (COYA) - Sof aktivlarga nisbatan bozor kapitallashuvi|VTGN - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Ovid Rx|Bozor kapitallashuvining balans qiymatiga nisbati ABOS|Bozor kapitallashuvining balans qiymatiga nisbati CRVO (CervoMed Corporation)|Bozor qiymatining balans qiymatiga nisbati Alterity Therapeutics Limited|Clene Inc - Balans qiymatiga nisbatan bozor qiymati|PEPG: Bozor qiymatining balans qiymatiga nisbati|JUNS - Kapitallashuvning sof aktivlarga nisbati|RLMD: Bozor kapitallashuvining balans qiymatiga nisbati|Annovis Bio Corporation (ANVS) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GRCE|Kapitallashuvning sof aktivlarga nisbati fireflyneuro.com|Klotho Neurosciences Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti neurosense-tx.com NRSN|Kapitallashuvning sof aktivlarga nisbati RVPH (Reviva Pharmaceuticals Holdings)|MTVA - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati NeurAxis, Inc. NRXS|HSDT - Bozor kapitallashuvining balans qiymatiga multiplikatori|passagebio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Neuphoria Therapeutics (NEUP) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati NERV|Kapitallashuvning sof aktivlarga nisbati Athira Pharma Corp|Bozor kapitallashuvining balans qiymatiga nisbati ADXN|Bozor kapitallashuvining balans qiymatiga nisbati ALZN (alzamend.com)|Bozor qiymatining balans qiymatiga nisbati Cyclerion Therapeutics, Inc. CYCN|Protagenic Therapeutics Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati KTTA (Pasithea)|CRGT: Balans qiymatiga nisbatan bozor kapitallashuvi|Avenue Therapeutics - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi brainstorm-cell.com|CARA (Cara Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CHRO|ELYM - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ITCI (intracellulartherapies.com)|LBPH - Bozor qiymatining balans qiymatiga nisbati|marinuspharma.com - Kapitallashuvning balans qiymatiga nisbati|NKGen Biotech (NKGN) - Bozor qiymatining balans qiymatiga nisbati|NRBO - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SAGE|Bozor qiymatining balans qiymatiga koeffitsiyenti Synaptogenix, Inc|TRVN (Trevena, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VIGL|Anew Medical, Inc. (WENA) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CERE (Cerevel Therapeutics Inc)